Excess Treatment Costs of Multiple Sclerosis: What Can We Learn From Longitudinal Population-Based Data?

Affiliations

• ¹ From the Comprehensive Clinical Trials Unit at UCL (E.B.), Institute of Clinical Trials and Methodology, University College London, United Kingdom; Department of Applied Health Research (R.M.H.), Institute of Epidemiology and Health Care, University College London, United Kingdom.
• ² From the Comprehensive Clinical Trials Unit at UCL (E.B.), Institute of Clinical Trials and Methodology, University College London, United Kingdom; Department of Applied Health Research (R.M.H.), Institute of Epidemiology and Health Care, University College London, United Kingdom. r.hunter@ucl.ac.uk.